stars 1 stars 2 stars 3

InSCREENeX GmbH is a privately held biotechnology company developing highly innovative cellular systems. The company's proprietary and award-winning CI-SCREEN technology is an enabling tool creating in vitro cell systems with an in vivo like physiology and unlimited availability. These unique cell systems advance basic research and the drug development process. In addition, the universal applicability allows the creation of cell systems from any donor thereby supporting personalized medicine and disease-in-a-dish approaches. Through strategic partnering with biotechnology companies and academic researchers these cell systems are used as building blocks for the creation of 3D tissues and organ-on-a-chip devices.

InSCREENeX GmbH Questions

The InSCREENeX GmbH annual revenue was $1 million in 2026.

InSCREENeX GmbH is based in Braunschweig, Lower Saxony.

The NAICS codes for InSCREENeX GmbH are [541, 5417, 54171, 54, 541713].

The SIC codes for InSCREENeX GmbH are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users